The Mouse Tumor Models Resource (MTMR) was established to: 1) facilitate translational research with the use of animal models for preclinical studies, and 2) consolidate animal expertise for in vivo studies using xenograft and transgenic models. The resource maintains a breeding colony of Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice and has established a tumor bank representing prostate cancer progression in TRAMP as well as several other widely used models of prostate cancer including the CWR22 model, HiMyc model, PBCre4VPten. In addition to prostate cancer models, MTMR also has a sarcoma model and a developing transgenic model of pancreatic cancer. The Resource has expertise in establishing xenografts from clinical samples and routinely grafts human cancer samples subcutaneously or under the renal capsule. MTMR also treats cohorts of animals, tracks tumor growth, and performs tissue procurement and post collection processing for histology and molecular analysis. MTMR offers investigators expertise in all standard small animal surgeries and procedures, including establishment of tumor xenograft (subcutaneous and subrenal), injections (iv, subQ, ip, intracardiac, intrafemoral, intraprosatatic), castration, oral gavage, maintenance of transgenic colonies, administration of specialized diets, tumor measurements and blood draws. The highly trained and experienced MTMR technical staff provide expertise in the use of in vivo models, and consolidated breeding colonies to ultimately provide high quality service at a significant cost savings to investigators. MTMR is comprised of two technicians who provide technical expertise and perform all services and two research scientists that provide oversight of operations and scientific consultation and budgetary evaluation. First priority for use is given to peer-review-funded RPCI CCSG members;second priority to non-peer-review-funded CCSG members;third priority to non-members and academic collaborators;and last priority to external users. During the reporting period, the Mouse Tumor Model Shared Resource has served 30 members from 5 research programs, with 66% utilization by CCSG members with peer reviewed funding. The CCSG support provides 18% of the overall proposed budget

Public Health Relevance

Animal models of human cancer are a vital resource in the quest to understand, prevent and cure cancer. The Mouse Tumor Model Resource provides the research community with a highly skilled staff and expertise in the appropriate use of animal models. The services provided by the Resource facilitate discovery in cancer biology and the rapid translation of bench science into in vivo studies which compliment translational clinical studies.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Ciamporcero, Eric; Miles, Kiersten Marie; Adelaiye, Remi et al. (2015) Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. Mol Cancer Ther 14:101-10
Ma, Yingyu; Hu, Qiang; Luo, Wei et al. (2015) 1?,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells. J Steroid Biochem Mol Biol 148:166-71
Shen, Li; Sundstedt, Anette; Ciesielski, Michael et al. (2015) Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models. Cancer Immunol Res 3:136-48
Adelaiye, Remi; Ciamporcero, Eric; Miles, Kiersten Marie et al. (2015) Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications. Mol Cancer Ther 14:513-22
Uekusa, Shota; Kawashima, Hiroyuki; Sugito, Kiminobu et al. (2014) Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon. Int J Oncol 44:1669-77
Ambrosone, Christine B; Zirpoli, Gary; Ruszczyk, Melanie et al. (2014) Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control 25:259-65
Röhm, Marc; Grimm, Melissa J; D'Auria, Anthony C et al. (2014) NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. Infect Immun 82:1766-77
Rohrbach, Daniel J; Muffoletto, Daniel; Huihui, Jonathan et al. (2014) Preoperative mapping of nonmelanoma skin cancer using spatial frequency domain and ultrasound imaging. Acad Radiol 21:263-70
Ambrosone, Christine B; Young, Allyson C; Sucheston, Lara E et al. (2014) Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget 5:237-48
O'Brien, Shalana; Golubovskaya, Vita M; Conroy, Jeffrey et al. (2014) FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics. Oncotarget 5:7945-59

Showing the most recent 10 out of 517 publications